( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)

Author name:
Limit:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):
Filter potential authors as well?

Potential publications

34 publications found

Click here to create clusters based on exact author strings rather than rougher matches.

Group #1

Matched potential author: Tobias Meißner - author of 18 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression[1]Mina Ali, [2]Ram Ajore, [3]Anna-Karin Wihlborg, [4]Abhishek Niroula, [5]Bhairavi Swaminathan, [6]Ellinor Johnsson, [7]Owen W Stephens, [8]Gareth J Morgan, [9]Tobias Meissner, [10]Ingemar Turesson, [11]Hartmut Goldschmidt, [12]Ulf-Henrik Mellqvist, [13]Urban Gullberg, [14]Markus Hansson, [15]Kari Hemminki, [16]Hareth Nahi, [17]Anders Waage, [18]Niels Weinhold, [19]Björn Nilsson [Full author list]Nature Communications [missing]DOI: 10.1038/S41467-018-04082-2 [ORCID]
PubMed: 29695719 [ORCID]
2018-04-25Tobias Meißner (Q55979561; 18 items)
Detection of Cross-Sample Contamination in Multiple Myeloma Samples and Sequencing Data[1]Owen W Stephens, [2]Tobias Meißner, [3]Niels Weinhold [Full author list]Methods in Molecular Biology [missing]DOI: 10.1007/978-1-4939-7865-6_10 [ORCID]
PubMed: 29797257 [ORCID]
2018-01-01Tobias Meißner (Q55979561; 18 items)
Genetic Predisposition to Multiple Myeloma at 5q15 Is Mediated by an ELL2 Enhancer Polymorphism[1]Ni Li, [2]David Christopher Johnson, [3]Niels Weinhold, [4]Kimberly M Scott, [5]Sara E Dobbins, [6]Jonathan S Mitchell, [7]Ben Kinnersley, [8]Amit Sud, [9]Philip J Law, [10]Giulia Orlando, ..., [17]Fadi Hariri, [18]Tomi Pastinen, [19]Tobias Meissner, [20]Hartmut Goldschmidt, [21]Kari Hemminki, ... [Full author list]Cell Reports [missing]DOI: 10.1016/J.CELREP.2017.08.062 [ORCID]
PubMed: 28903037 [ORCID]
2017-09-01Tobias Meißner (Q55979561; 18 items)
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma[1]Leo Rasche, [2]Edgardo Angtuaco, [3]James E McDonald, [4]Amy Buros, [5]Caleb Stein, [6]Charlotte Pawlyn, [7]Sharmilan Thanendrarajan, [8]Carolina Schinke, [9]Rohan Samant, [10]Shmuel Yaccoby, ..., [13]Maurizio Zangari, [15]Tobias Meissner, [16]Hartmut Goldschmidt, [17]Kari Hemminki, ... [Full author list]Blood [missing]DOI: 10.1182/BLOOD-2017-03-774422 [ORCID]
PubMed: 28432222 [ORCID]
tomography [missing]2017-04-21Tobias Meißner (Q55979561; 18 items)
The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells[1]Niels Weinhold, [2]Tobias Meissner, [3]David Christopher Johnson, [4]Anja Seckinger, [5]Jérôme Moreaux, [6]Asta Försti, [7]Bowang Chen, [8]Jolanta Nickel, [9]Daniel Chubb, [10]Andy C Rawstron, ... [Full author list]Haematologica [missing]DOI: 10.3324/HAEMATOL.2014.118786 [ORCID]
PubMed: 25480495 [ORCID]
2014-12-05Tobias Meißner (Q55979561; 18 items)
Immunomodulatory drugs thalidomide and lenalidomide affect osteoblast differentiation of human bone marrow stromal cells in vitro.[1]Arnold Bolomsky, [2]Martin Schreder, [3]Tobias Meißner, [4]Dirk Hose, [5]Heinz Ludwig, [6]Sabine Pfeifer, [7]Niklas Zojer [Full author list]Experimental Hematology [missing]DOI: 10.1016/J.EXPHEM.2014.03.005 [ORCID]
PubMed: 24704163 [ORCID]
thalidomide [missing]; osteoblast [missing]2014-04-02Tobias Meißner (Q55979561; 18 items)
Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6.[1]Mathias Witzens-Harig, [2]Dirk Hose, [3]Simone Jünger, [4]Christina Pfirschke, [5]Nisit Khandelwal, [6]Ludmila Umansky, [7]Anja Seckinger, [8]Heinke Conrad, [9]Bettina Brackertz, [10]Thierry Rème, [11]Brigitte Gueckel, [12]Tobias Meißner, [13]Michael Hundemer, [14]Anthony D Ho, [15]Jean-Francois Rossi, [16]Kai Neben, [17]Helga Bernhard, [18]Hartmut Goldschmidt, [19]Bernard Klein, [20]Philipp Beckhove [Full author list]Blood [missing]DOI: 10.1182/BLOOD-2012-05-429415 [ORCID]
PubMed: 23603913 [ORCID]
cell adhesion [missing]2013-04-19Tobias Meißner (Q55979561; 18 items)
Thalidomide maintenance therapy maturates the T cell compartment and compromises antigen-specific antitumor immunity in patients with multiple myeloma.[1]Isabelle Herth, [2]Mathias Witzens-Harig, [3]Philipp Beckhove, [4]Dirk Hose, [5]Tobias Meissner, [6]Brigitte Neuber, [7]Melanie Engelhardt, [8]Jürgen Haas, [9]Kai Neben, [10]Anthony D Ho, [11]Bernard Klein, [12]Hartmut Goldschmidt, [13]Michael Hundemer [Full author list]Experimental Hematology [missing]DOI: 10.1016/J.EXPHEM.2012.10.018 [ORCID]
PubMed: 23142220 [ORCID]
thalidomide [missing]2012-11-08Tobias Meißner (Q55979561; 18 items)
Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routine[1]Tobias Meissner, [2]Anja Seckinger, [3]Thierry Rème, [4]Thomas Hielscher, [5]Thomas Möhler, [6]Kai Neben, [7]Hartmut Goldschmidt, [8]Bernard Klein, [9]Dirk Hose [Full author list]Clinical Cancer Research [missing]DOI: 10.1158/1078-0432.CCR-11-1628 [ORCID]
PubMed: 21986844 [ORCID]
2011-10-10Tobias Meißner (Q55979561; 18 items)
Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays[1]Karène Mahtouk, [2]Jérôme Moreaux, [3]Dirk Hose, [4]Thierry Rème, [5]Tobias Meissner, [6]Michel Jourdan, [7]Jean François Rossi, [8]Steven T Pals, [9]Hartmut Goldschmidt, [10]Bernard Klein [Full author list]BMC Cancer [missing]DOI: 10.1186/1471-2407-10-198 [ORCID]
PubMed: 20465808 [ORCID]
multiple myeloma [missing]; bone marrow [missing]2010-05-13Tobias Meißner (Q55979561; 18 items)
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor[1]Anne Catherine Sprynski, [2]Dirk Hose, [3]Laurent Caillot, [4]Thierry Réme, [5]John D Shaughnessy, [6]Bart Barlogie, [7]Anja Seckinger, [8]Jérôme Moreaux, [9]Michael Hundemer, [10]Michel Jourdan, [11]Tobias Meissner, [12]Anna Jauch, [13]Karène Mahtouk, [14]Alboukadel Kassambara, [15]Uta Bertsch, [16]Jean François Rossi, [17]Hartmut Goldschmidt, [18]Bernard Klein [Full author list]Blood [missing]DOI: 10.1182/BLOOD-2008-07-170464 [ORCID]
PubMed: 19228610 [ORCID]
2009-02-18Tobias Meißner (Q55979561; 18 items)
Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma[1]Dirk Hose, [2]Thierry Rème, [3]Tobias Meissner, [4]Jérôme Moreaux, [5]Anja Seckinger, [6]Joe Lewis, [7]Vladimir Benes, [8]Axel Benner, [9]Michael Hundemer, [10]Thomas Hielscher, ... [Full author list]Blood [missing]DOI: 10.1182/BLOOD-2008-09-178350 [ORCID]
PubMed: 19171872 [ORCID]
multiple myeloma [missing]2009-01-26Tobias Meißner (Q55979561; 18 items)

Group #2

TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Oxidized Carbo-Iron causes reduced reproduction and lower tolerance of juveniles in the amphipod Hyalella azteca[1]Mirco Weil, [2]Tobias Meißner, [3]Armin Springer, [4]Mirco Bundschuh, [5]Lydia Hübler, [6]Ralf Schulz, [7]Karen Duis [Full author list]Aquatic Toxicology [missing]DOI: 10.1016/J.AQUATOX.2016.10.028 [ORCID]
PubMed: 27825064 [ORCID]
Hyalella azteca [missing]2016-11-02
Towards sensible toxicity testing for nanomaterials: proposal for the specification of test design[1]Annegret Potthoff, [2]Mirco Weil, [3]Tobias Meißner, [4]Dana Kühnel [Full author list]Science and Technology of Advanced Materials [missing]DOI: 10.1088/1468-6996/16/6/065006 [ORCID]
PubMed: 27877848 [ORCID]
nanomaterial [missing]2015-12-09
The oxidized state of the nanocomposite Carbo-Iron® causes no adverse effects on growth, survival and differential gene expression in zebrafish[1]Mirco Weil, [2]Tobias Meißner, [3]Wibke Busch, [4]Armin Springer, [5]Dana Kühnel, [6]Ralf Schulz, [7]Karen Duis [Full author list]Science of the Total Environment [missing]DOI: 10.1016/J.SCITOTENV.2015.05.087 [ORCID]
PubMed: 26042533 [ORCID]
nanocomposite [missing]2015-05-29
Implications of the stability behavior of zinc oxide nanoparticles for toxicological studies[1]Tobias Meißner, [2]Kathrin Oelschlägel, [3]Annegret Potthoff [Full author list]International nano letters [missing]DOI: 10.1007/S40089-014-0116-5 [ORCID]
nanoparticle [missing]; zinc oxide nanoparticles [missing]2014-08-30
Quantification of Al2O3 nanoparticles in human cell lines applying inductively coupled plasma mass spectrometry (neb-ICP-MS, LA-ICP-MS) and flow cytometry-based methods[1]Steffi Böhme, [2]Hans-Joachim Stärk, [3]Tobias Meißner, [4]Armin Springer, [5]Thorsten Reemtsma, [6]Dana Kühnel, [7]Wibke Busch [Full author list]Journal of Nanoparticle Research [missing]DOI: 10.1007/S11051-014-2592-Y [ORCID]
PubMed: 25285033 [ORCID]
nanoparticle [missing]; flow cytometry [missing]2014-08-08
Transport of carbon colloid supported nanoscale zero-valent iron in saturated porous media[1]Jan Busch, [2]Tobias Meißner, [3]Annegret Potthoff, [4]Sascha E Oswald [Full author list]Journal of Contaminant Hydrology [missing]DOI: 10.1016/J.JCONHYD.2014.05.006 [ORCID]
PubMed: 24914524 [ORCID]
colloid [missing]; environmental chemistry [missing]2014-05-27
Investigations on mobility of carbon colloid supported nanoscale zero-valent iron (nZVI) in a column experiment and a laboratory 2D-aquifer test system[1]Jan Busch, [2]Tobias Meißner, [3]Annegret Potthoff, [4]Sascha E Oswald [Full author list]Environmental Science and Pollution Research [missing]DOI: 10.1007/S11356-014-3049-7 [ORCID]
PubMed: 24859704 [ORCID]
colloid [missing]; aquifer [missing]2014-05-27
Comparative evaluation of particle properties, formation of reactive oxygen species and genotoxic potential of tungsten carbide based nanoparticles in vitro[1]Dana Kühnel, [2]Katja Scheffler, [3]Peggy Wellner, [4]Tobias Meißner, [5]Annegret Potthoff, [6]Wibke Busch, [7]Armin Springer, [8]Kristin Schirmer [Full author list]Journal of Hazardous Materials [missing]DOI: 10.1016/J.JHAZMAT.2012.04.070 [ORCID]
PubMed: 22698683 [ORCID]
tungsten [missing]; nanoparticle [missing]; reactive oxygen species [missing]; genotoxicity [missing]2012-05-05
Internalisation of engineered nanoparticles into mammalian cells in vitro: influence of cell type and particle properties[1]Wibke Busch, [2]Susanne Bastian, [3]Ulrike Trahorsch, [4]Maria Iwe, [5]Dana Kühnel, [6]Tobias Meißner, [7]Armin Springer, [8]Michael Gelinsky, [9]Volkmar Richter, [10]Chrysanthy Ikonomidou, [11]Annegret Potthoff, [12]Irina Lehmann, [13]Kristin Schirmer [Full author list]Journal of Nanoparticle Research [missing]DOI: 10.1007/S11051-010-0030-3 [ORCID]
nanoparticle [missing]2010-07-30
Physical-chemical characterization of tungsten carbide nanoparticles as a basis for toxicological investigations[1]Tobias Meissner, [2]Dana Kühnel, [3]Wibke Busch, [4]Steffen Oswald, [5]Volkmar Richter, [6]Alexander Michaelis, [7]Kristin Schirmer, [8]Annegret Potthoff [Full author list]Nanotoxicology [missing]DOI: 10.3109/17435391003605455 [ORCID]
PubMed: 20795896 [ORCID]
2010-06-01
Tungsten carbide and tungsten carbide cobalt nanoparticle toxicity: The role of cellular particle uptake, leached ions and cobalt bioavailability[1]Wibke Busch, [2]Dana Kühnel, [3]Armin Springer, [4]Tobias Meißner, [5]Michael Gelinsky, [6]Annegret Potthoff, [7]Stefan Scholz, [8]Volkmar Richter, [9]Kristin Schirmer [Full author list]Toxicology Letters [missing]DOI: 10.1016/J.TOXLET.2009.06.645 [ORCID]
cobalt [missing]; tungsten [missing]; nanoparticle [missing]; bioavailability [missing]2009-09-01
Physico-chemical characterization in the light of toxicological effects[1]Tobias Meissner, [2]Annegret Potthoff, [3]Volkmar Richter [Full author list]Inhalation Toxicology [missing]DOI: 10.1080/08958370902942608 [ORCID]
PubMed: 19558232 [ORCID]
2009-07-01
Agglomeration of tungsten carbide nanoparticles in exposure medium does not prevent uptake and toxicity toward a rainbow trout gill cell line[1]Dana Kühnel, [2]Wibke Busch, [3]Tobias Meissner, [4]Armin Springer, [5]Annegret Potthoff, [6]Volkmar Richter, [7]Michael Gelinsky, [8]Stefan Scholz, [9]Kristin Schirmer [Full author list]Aquatic Toxicology [missing]DOI: 10.1016/J.AQUATOX.2009.04.003 [ORCID]
PubMed: 19439373 [ORCID]
tungsten [missing]; nanoparticle [missing]; cell line [missing]2009-04-17
Toxicity of tungsten carbide and cobalt-doped tungsten carbide nanoparticles in mammalian cells in vitro[1]Susanne Bastian, [2]Wibke Busch, [3]Dana Kühnel, [4]Armin Springer, [5]Tobias Meissner, [6]Roland Holke, [7]Stefan Scholz, [8]Maria Iwe, [9]Wolfgang Pompe, [10]Michael Gelinsky, [11]Annegret Potthoff, [12]Volkmar Richter, [13]Chrysanthy Ikonomidou, [14]Kristin Schirmer [Full author list]Environmental Health Perspectives [missing]DOI: 10.1289/EHP.0800121 [ORCID]
PubMed: 19440490 [ORCID]
cobalt [missing]; tungsten [missing]; nanoparticle [missing]2008-12-01

Group #3

Matched potential author: Tobias Meißner - author of 18 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine[1]Christoph Röcken, [2]Anu Amallraja, [3]Christine Halske, [4]Luka Opasic, [5]Arne Traulsen, [6]Hans-Michael Behrens, [7]Sandra Krüger, [8]Anne Liu, [9]Jochen Haag, [10]Jan-Hendrik Egberts, [11]Philip Rosenstiel, [12]Tobias Meißner [Full author list]Genome Medicine [missing]DOI: 10.1186/S13073-021-00975-Y [ORCID]
PubMed: 34749812 [ORCID]
2021-11-08Tobias Meißner (Q55979561; 18 items)
Case Report - 16 Year Life History and Genomic Evolution of an ER+ HER2- Breast Cancer[1]Bing Xu, [2]Anu Amallraja, [3]Padmapriya Swaminathan, [4]Rachel Elsey, [5]Christel Davis, [6]Stephanie Theel, [7]Sarah Viet, [8]Jason Petersen, [9]Amy Krie, [10]Gareth Davies, [11]Casey B Williams, [12]Erik Ehli, [13]Tobias Meissner [Full author list]Cold Spring Harbor molecular case studies [missing]DOI: 10.1101/MCS.A005629 [ORCID]
PubMed: 33008833 [ORCID]
2020-10-02Tobias Meißner (Q55979561; 18 items)
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial[1]Thomas Karn, [2]Tobias Meissner, [3]Karsten E Weber, [4]Christine Solbach, [5]Carsten Denkert, [6]Knut Engels, [7]Peter A. Fasching, [8]Bruno Valentin Sinn, [9]Iris Schrader, [10]Jan Budczies, ... [Full author list]Clinical Cancer Research [missing]DOI: 10.1158/1078-0432.CCR-19-1954 [ORCID]
PubMed: 31932495 [ORCID]
bevacizumab [missing]2020-01-13
RNA based individualized drug selection in breast cancer patients without patient-matched normal tissue[1]Michael Forster, [2]Adam Mark, [3]Friederike Egberts, [4]Elisa Rosati, [5]Elke Rodriguez, [6]Martin Stanulla, [7]Dirk Bauerschlag, [8]Christian Schem, [9]Nicolai Maass, [10]Anu Amallraja, ..., [22]Casey B Williams, [23]Andre Franke, [24]Tobias Meißner [Full author list]Oncotarget [missing]DOI: 10.18632/ONCOTARGET.25981 [ORCID]
PubMed: 30190792 [ORCID]
2018-08-17Tobias Meißner (Q55979561; 18 items)
Metastatic triple-negative breast cancer patient with TP53 tumor mutation experienced 11 months progression-free survival on bortezomib monotherapy without adverse events after ending standard treatments with grade 3 adverse events[1]Tobias Meißner, [2]Adam Mark, [3]Casey Williams, [4]Wolfgang E Berdel, [5]Stephanie Wiebe, [6]Andrea Kerkhoff, [7]Eva Wardelmann, [8]Timo Gaiser, [9]Carsten Müller-Tidow, [10]Philip Rosenstiel, [11]Norbert Arnold, [12]Brian Leyland-Jones, [13]Andre Franke, [14]Martin Stanulla, [15]Michael Forster [Full author list]Cold Spring Harbor molecular case studies [missing]DOI: 10.1101/MCS.A001677 [ORCID]
PubMed: 28679691 [ORCID]
triple-negative breast cancer [missing]2017-07-05Tobias Meißner (Q55979561; 18 items)

Potential author items

NameDescriptionAuthored itemsIdentifiersEmployer(s)
Tobias Meißnerresearcher18ORCID: 0000-0002-9680-7153
VIAF ID: 177555932
Avera McKennan Hospital & University Health Center [missing]
Scripps Research [missing]
University Hospital Heidelberg [missing]
Tobias W Meissnerresearcher4ORCID: 0000-0003-3972-5386
VIAF ID: 305930073
Technical University of Dortmund [missing]
Ruhr University Bochum [missing]
Tobias O. MeißnerGerman author1ISNI: 0000000109094267
VIAF ID: 64169324
Tobias MeissnerGerman Esperantist0
Tobias Meißnerbadminton player0
Other Q number of this author

New Author Item

(if the author you are looking for is not listed above and otherwise not yet in Wikidata)
Author name:
Check ORCID for Tobias Meißner | Author has ORCID ID:
Check VIAF for Tobias Meißner | Author has VIAF ID:
Check ResearchGate for Tobias Meißner | Author has ResearchGate Profile ID:
After creating the new author item, enter the Wikidata ID in the "Other Q number of this author" field above to link to their works.

Author items in these papers

Common author name strings in these papers

Publishing venues for these papers

Topics for these papers


Feedback
Source and documentation (at github)
Wikidata page